Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630044 · ClinicalTrials.gov registry record · NA
Neurostimulation Device for Treatment of Migraine Headache
A NA study, sponsored by Scion NeuroStim.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01630044: Completed NA study, sponsored by Scion NeuroStim.
NCT01630044 is a NA study that has completed, run by Scion NeuroStim. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630044, a NA study, has completed, sponsored by Scion NeuroStim.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform to apply.
Primary Outcome
Daily Headache Diary will be used by subject. A headache day is defined as a twenty-four hour period which the subject has a headache.
Interventions
- DEVICE TNM device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01630044 record still lists
NCT01630044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which TNM device is the first listed.
NCT01630044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01630044 about?
NCT01630044 is a clinical study titled "Neurostimulation Device for Treatment of Migraine Headache". This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform to apply.
What is the current status of trial NCT01630044?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2012-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01630044?
The interventions under investigation include: TNM device (DEVICE).
Who is sponsoring clinical trial NCT01630044?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01630044's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia